[Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice].
Sugiura
M
M
Suenaga
H
H
Kasuya
Y
Y
Kamata
K
K
D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000503:physiopathology; D006937:Hypercholesterolemia / Q000150:complications*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D017035:Pravastatin / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014664:Vasodilation / Q000187:drug effects
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D002792:Cholestyramine Resin; D017035:Pravastatin